MoneyWorks4Me

SMS Pharmaceuticals informs about transcript of conference call

18 Nov 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, SMS Pharmaceuticals has informed that it attached the transcript of the Conference Call held on Friday, 10th November, 2023 for the second quarter and half year ended 30th September, 2023. A copy of the said Transcript is being uploaded on the website of the Company www.smspharma.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..